NCT04941326 The Effect of Spinal Mobilization on Respiratory Parameters in Parkinson's Disease Patients
| NCT ID | NCT04941326 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abant Izzet Baysal University |
| Condition | Parkinson Disease |
| Study Type | INTERVENTIONAL |
| Enrollment | 63 participants |
| Start Date | 2021-08-15 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 63 participants in total. It began in 2021-08-15 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Parkinson's patients suffer from respiratory distress for different reasons. It is thought that physiotherapy methods that have an indirect effect on the diaphragm can improve respiratory functions. The aim of this study is to investigate the effects of spinal mobilization and diaphragmatic breathing techniques on respiratory function.
Eligibility Criteria
Inclusion Criteria: * Have been diagnosed with Parkinson's disease * Volunteering to participate in the study * Modified Medical Research Council (MMRC) score \>2 Exclusion Criteria: * Those with COVID-19 * Diseases that increase intra-abdominal pressure * Diseases affecting diaphragmatic motility * Those who had a recent thoracic or abdominal operation * Those who have a parenchymal, pleural or chest wall mass that will cause restriction on a recent chest X-ray or CT will not be included in the study
Contact & Investigator
Ramazan Kurul, Ph.D
PRINCIPAL INVESTIGATOR
Abant Izzet Baysal University
Frequently Asked Questions
Who can join the NCT04941326 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 85 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04941326 currently recruiting?
Yes, NCT04941326 is actively recruiting participants. Contact the research team at ramazankurul2@hotmail.com for enrollment information.
Where is the NCT04941326 trial being conducted?
This trial is being conducted at Bolu, Turkey (Türkiye), Bolu, Turkey (Türkiye).
Who is sponsoring the NCT04941326 clinical trial?
NCT04941326 is sponsored by Abant Izzet Baysal University. The principal investigator is Ramazan Kurul, Ph.D at Abant Izzet Baysal University. The trial plans to enroll 63 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.